A metabonomics study on crohn's disease using nuclear magnetic resonance spectroscopy

HealthMED

Volumn 6, Issue 11, 2012, Pages 3577-3583

  Fathi, Fariba ^a   Kyani, Anahita ^b   Nejad, Mohamad Rostami ^c   Rezaye Tavirani, Mostafa ^c   Naderi, Nosratollah ^c   Zali, Mohamad Reza ^c   Tafazzoli, Mohsen ^a   Oskouie, Afsaneh Arefi ^c  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Classification and regression tree; Crohn's disease; Metabonomics; Nuclear magnetic resonance spectroscopy

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ALANINE; ALPHA TOCOPHEROL; ARGININE; BIOLOGICAL MARKER; CITRIC ACID; CREATINE; CREATININE; DIACYLGLYCEROL; GLUCOSE; GLUTAMINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LIPID; MONOACYLGLYCEROL; PHOSPHOLIPID; PYRUVIC ACID; VALINE; VITAMIN; ZINC;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DATA PROCESSING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MALE; METABOLITE; METABOLOMICS; MODEL; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; RECOGNITION; SENSITIVITY AND SPECIFICITY;

EID: 84871981446     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baumgart D, Carding S. Inflammatory bowel disease: cause and immunobiology. The Lancet 2007;369:1627-40.
2. Baumgart D, Sandborn W. Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet 2007;369:1641-57.
3. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-34.
4. Loftus EVJ. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-17.
5. Stephen BH. Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001;96:635-43.
6. German JB., Hammock BD, Watkins SM., Metabolomics: Building on a century of biochemistry to guide human health. Metabolomics. 2005; 1:3-9.
7. Nicholson J., Lindon J., Holmes E., Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181-9.
8. Nicholson J. Connelly J. Lindon J. Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002:153-61.
9. Hong Y-S., Hong KS., Park M-H., Ahn Y-T., Lee J-H., Huh C-S., et al. Metabonomic Understanding of Probiotic Effects in Humans With Irritable Bowel Syndrome. J Clin Gastroenterol 2011(45):415-25.
10. Dryland PA. Love DR. Walker MF. Dommels Y, Butts C, Rowan D, et al. Allantoin as A Biomarker of Inflammation in an Inflammatory Bowel Disease Mouse Model: NMR Analysis of Urine. The Open Bioactive Compounds Journal. 2008;1:1-6.
11. Bezabeh T, Somorjai RL, Smith ICP. MR metabolomics of fecal extracts:applications in the study of bowel diseases. Magn Reson Chem. 2009;47:54-61.
12. Gall GL. Noor SO. Ridgway K, Scovell L, Jamieson C, Johnson IT, et al. Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome. J Proteome Res. 2011;10:4208-18.
13. Jansson JK, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. Plos one. 2009;4:1-10.
14. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease. J Proteome Res 2007;6:546-51.
15. Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, Slupsky CM. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem. 2008 80:5524-31.
16. Breiman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. Chapman &Hall (Wadsworth I, editor. New York; 1984.
17. Cao D-S, Zeng M-M, Yi L-Z, Wang B, X Q-S., Hud Q-N., et al. A novel kernel Fisher discriminant analysis: Constructing informative kernel by decision tree ensemble for metabolomics data analysis. AnalChemActa. 2011;706:97-104.
18. Aymerich FX, Alonso J, Cabañas ME, Comabella M, Sobrevilla P, Rovira A. Decision tree based fuzzy classifier of 1H magnetic resonance spectra from cerebrospinal fluid samples. FuzzySetSyst. 2011;170:43-63.
19. Deconinck E, Sacré PY, Coomans D, Beer JD. Classification trees based on infrared spectroscopic data to discriminate between genuine and counterfeit medicines. J Pharmaceut Biomed Anal. 2012;57:68-75.
20. Zhang G, Hirasaki G. CPMG relaxation by diffusion with constant magnetic field gradient in a restricted geometry: numerical simulation and application. J Magn Reson 2003;163:81-91.
21. Viant MR. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Commun. 2003;310:943-8.
22. Holmes E, Nicholis AW, Lindon JC, Ramos S, Spraul M, Neidig P, et al. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 1998;11:235-44.
23. Waters NJ, Holmes E, Williams A, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem Res Toxicol. 2001;14:1401-12.
24. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. Introduction to multi and megavariate data analysis using projection methods, PCA and PLS. UMETRICS. 1999:213-25.
25. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995;67 793-811.
26. Fan M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc. 1996;28:161-219.
27. Lindon JC. NMR Spectroscopy on biofluids. Annu Rep NMR Spectrosc. 1999;38:1-88.
28. Zhang MH, Xu QS, Daeyaert F, Lewi PJ, Massart DL. Application of boosting to classification problems in chemometrics. Anal Chim Acta. 2005;544:167-76.
29. Breiman L, Friedman JH, Olshen RA, Stone CJ, Classification and Regression Trees. Group WI, editor.: Belmont; 1984.
30. Deconinck E, Hancock T, Coomans D, Massart DL, Heyden YV. Classification of drugs in absorption classes using Classification And Regression Trees (CART)-methodology. J Pharm Biomed Anal. 2005;39: 91-103.
31. Deconinck E, Zhang MH, Coomans D, Heyden YV. Classification tree models for the prediction of blood-brain barrier passage of drugs. J Chem InfModel. 2006;46:1410-9.
32. De'ath G, Fabricius K. Classification and regression trees: a powerful yet simple technique for ecological data analysis. Ecology,. 2000;81:3178-92.
33. Snee RD. Validation of regression models: methods and examples. Technometrics. 1977;19:415-28.
34. Deconinck E, Sacré PY, Coomans D, DeBeer J. Classification trees based on infrared spectroscopic data to discriminate between genuine and counterfeit medicines. J Pharm Biomed Anal. 2012; 57:68-75.
35. Jones A, Young D, Taylor J, Kell DB, Rowland JJ. quantification of microbial productivity via multiangle light scattering and supervised learning. Biotechnol Bioeng 1998;59:131-43.
36. Massart DL, Vandeginste BGM, Buydens LMC, Jong SD, Lewi PJ, Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics. Science E, editor. Amsterdam; 1997.
37. Hrabovsky V, Zadak Z, Blaha V, Hyspler R, Ticha A, Karlik T. Lipid Metabolism In Active Crohn's Disease: Pre-Results. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150:363-6.
38. Kuroki F, Iida M, Tominaga M, Matsumoto T, Kanamoto K, Fujishima M. Is vitamin E depleted in Crohn's disease at initial diagnosis? DigDis. 1994;12:248-54.
39. Rubinstein HM, Dietz AA, Srinivasan R. Relation of vitaminE and serumlipids. Clin Chim Acta. 1969;23:1-6.
40. Horwitt MK, Harvey CC, Dahm CHJ, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci. 1972;203:223-36.
41. Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, et al. Vitamin status in patients with inflammatory bowel disease. Scand J Gastroenterol 1989;40:744-8.
42. Kuroki F, Iida M, Tominaga M, Matsumoto T, Hirakawa K, Sugiyama S, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. DigDisSci. 1993;38:1614-8.
43. Kohavi R, Provost F. Glossary of Terms. Machine Learning. 1998;30:271-4.